(AOF) – Transgene announces the appointment of Lucie Larguier to the position of financial director, with immediate effect. This biotech which designs and develops immunotherapies against cancer based on viral vectors specifies that it will be responsible for the strategy, management and financial operations of the company in order to accelerate the development of Transgene’s portfolio of innovative immunotherapies . LucieLarguier, previously vice-president of corporate communications and investor relations, succeeds Arnaud Dubarry.
Lucie Larguier spent more than 10 years as a communications consultant, and “contributed to the success of numerous market operations by advising her clients on their institutional and financial messages”. A graduate of the Paris Institute of Political Studies, Lucier Larguier holds a Master’s degree in communication and a specialization in finance.
© 2024 Agence Option Finance (AOF) – All reproduction rights reserved by AOF. AOF collects its data from the sources it considers the safest. However, the reader remains solely responsible for their interpretation and use of the information made available to them. The reader must therefore hold AOF and its contributors harmless from any claim resulting from this use. Agence Option Finance (AOF) is a brand of the Option Finance group
Did you like this article ? Share it with your friends using the buttons below.
